Sibanye Stillwater WKN: A2PWVQ ISIN: ZAE000259701 Forum: Aktien Thema: Hauptdiskussion

Johannesburg, 2. April 2026: Sibanye-Stillwater (Ticker JSE: SSW und NYSE: SBSW) gibt gemäß den Absätzen 6.77 bis 6.90 der JSE Limited Listings Requirements Folgendes bekannt: Name Themba George Nkosi Position Vorgeschriebene Führungskraft (Chief People and Culture Officer) Unternehmen Sibanye Stillwater Limited Art der Beteiligung Direkt und wirtschaftlich Art der Transaktion Kauf von Aktien am Markt Transaktionsdatum 31. März 2026 Anzahl der Aktien 11.865 Wertpapiergattung Stammaktien Marktpreis 49,72 R Gesamtwert 589.927,80

RBC Capital maintains a "Buy" rating on Sibanye-Stillwater (SBSW), recently raising the target price to $18.50 for ADRs in March 2026, citing a strong rebound, successful debt reduction, and a positive new strategy. Analysts note improved performance following a period of underperformance relative to other PGMs and gold producers.

Heraeus Precious Metals and Sibanye-Stillwater (JSE: SSW and NYSE: SBSW) have partnered on a new joint research and development project aimed at developing the generation of innovative, cost-efficient glass fibre bushings. The initiative focuses on platinum-palladium (PtPd) alloys enhanced through Heraeus’ proprietary dispersion hardening (DPH) technology, with the goal of enabling more economical glass fibre production while supporting the development of new palladium applications. Bushings are a critical component in the manufacturing of glass fibres, a market that continues to see strong global demand growth driven by construction, automotive, wind energy and electronics applications. Traditionally, bushings are made from platinum due to the metal’s excellent high-temperature stability. The collaboration aims to partially substitute platinum with palladium to achieve lower material costs and increase demand for palladium. A key challenge lies in identifying the optimal alloy composition. While increasing palladium content can significantly reduce costs, excessive substitution may compromise mechanical strength and lifetime under high-temperature operating conditions. To address this, Heraeus will apply and further adapt its proprietary DPH process – an oxide dispersion strengthening (ODS) technology – to enhance the material’s resistance and durability. The project will cover alloy development prototyping and customer validation, planned over a two-year period. The aim is to bring market-ready bushing solutions that are specifically tailored to glass fibre applications such as E-glass fibres (alumino-borosilicate glass fibres used for production of reinforced plastics including printed circuit boards and wind turbine blades), where cost efficiency is a key driver. For Sibanye-Stillwater, the collaboration is part of a broader strategy to foster new demand streams for palladium and support more balanced demand for platinum group metals (PGMs) that better match the basket of supply. By enabling the substitution of platinum in industrial applications, the project contributes to unlocking additional value for palladium while addressing evolving market dynamics. Heraeus will contribute its expertise in research and development, precious metals processing, and commercialisation, with development activities taking place in Hanau, Germany, and Shanghai, China. Sibanye-Stillwater will support the project as a strategic partner, contributing its expertise in PGMs and enabling the exploration of new application areas for palladium. “By combining our expertise in advanced materials engineering with Sibanye-Stillwater’s strength in PGM supply, we aim to unlock new pathways for cost-efficient glass fibre production,” said Thomas Stenger, Head of Business Line Functional Materials at Heraeus Precious Metals. “Our DPH technology enables us to tailor alloy properties in a way that balances performance and cost, making this approach particularly attractive for applications where economic efficiency is critical.” “Developing new, sustainable and diversified demand streams for palladium is a key priority for Sibanye-Stillwater. Collaborations such as this with Heraeus Precious Metals enable us to support innovation in industrial applications while helping to sustain a balanced demand across the 6E platinum group metals basket in response to changing market dynamics”, said Richard Stewart, CEO of Sibanye-Stillwater. The collaboration reflects both companies’ commitment to driving innovation in platinum group metal applications and addressing evolving market demands through material efficiency and technological advancement. Heraeus and Sibanye-Stillwater have recently collaborated on the development of a breakthrough ruthenium-based catalyst for Proton Exchange Membrane (PEM) water electrolysis, thereby significantly reducing material costs and reliance on iridium for hydrogen production.

Johannesburg, 17 April 2026: Sibanye-Stillwater (JSE: SSW and NYSE: SBSW) and the South African Nuclear Energy Corporation SOC Ltd (Necsa) are pleased to announce their research collaboration. The collaboration aims to advance the development of a radioactive palladium isotope derived from rhodium for use in Targeted Radionuclide Therapy. The radioactive isotope Palladium-103 is currently used in Brachytherapy to treat localised tumours, including prostate cancer, by delivering radiation directly to the affected area, thereby limiting exposure to surrounding healthy tissue. Rhodium is a platinum group metal (PGM) produced and refined by Sibanye-Stillwater at its South African operations. Under the first phase of the project, Necsa will test and verify that the rhodium meets radionuclide production standards and will conduct further chemical work, including the production of high- purity Palladium-103 (Pd-103), which could eventually be used in Targeted Radionuclide Therapy. The second phase of the project will see the parties collaborate on developing other nuclear medicine applications using rhodium and other PGMs produced by Sibanye-Stillwater. PGMs are already used in a range of medical applications, including diagnostic imaging and medical devices. Mr Loyiso Tyabashe, Group CEO of Necsa, said: “This collaboration brings together complementary strengths to advance research in nuclear medicine, while deepening South Africa’s sovereign capability in radiopharmaceutical innovation. Our vision is not only to contribute to the next generation of precision cancer therapies, but also to strengthen the country’s role as a globally respected centre of excellence in nuclear research.” Richard Stewart, Chief Executive Officer of Sibanye-Stillwater, commented: “Our collaboration with Necsa reinforces Sibanye-Stillwater’s philosophy to invest in research and development opportunities to find new applications for our metals. Supporting advancements in healthcare through the potential use of our rhodium in nuclear medicine aligns strongly with our purpose to create a better future for people and planet through our metals.” For further information on the applications of Sibanye-Stillwater’s metals, please refer to our website: https://www.sibanyestillwater.com/about-us/about-pgms/

Johannesburg, 20 April 2026: Sibanye-Stillwater (Tickers JSE: SSW and NYSE: SBSW) advises shareholders that the Group will publish the presentation for its International and Recycling operations Capital markets day on its website on 20 April 2026 at 08h00 (CAT) / 09h00 (EEST/Finland) / 06h00 (GMT) / 02h00 (EST) / 00h00 (MST). Stakeholders are advised that the presentation contains new information including cost, capital and production outlook for the Group’s International and Recycling operations that has not previously been published and will be available at https://www.sibanyestillwater.com/news-investors/presentations/ .

Johannesburg, 27. März 2026: Sibanye-Stillwater (Tickers JSE: SSW und NYSE: SBSW) gibt gemäß den Absätzen 6.77 bis 6.90 der JSE Limited Listings Requirements Folgendes bekannt: Name Richard Stewart Position Vorstandsmitglied und verantwortliche Person Unternehmen Sibanye Stillwater Limited Art der Beteiligung Direkt und wirtschaftlich Art der Transaktion Kauf von Aktien am Markt Transaktionsdatum 26. März 2026 Anzahl der Aktien 41.229 Wertpapiergattung Stammaktien Marktpreis 47,00 R Gesamtwert 1.937.763 R

Exactly!

Ich habe oft den Eindruck, daß bei steigenden Goldpreisen SSW der Goldbereich als marginales Nebengeschäft gesehen wird, bei fallendem Goldpreis sich der Focus auf 'diesen' Geschäftsbereich richtet. Aber ich bin zuversichtlich, daß der Mix bei SSW letztlich gute Ergebnisse bringt und die Zahlen auch die Anleger überzeugen.

Edelmetalle ordentlich im Plus, Sibanye fällt...😑

Hoffen wir, dass dieser Nahostkrieg der USA schnell endet und die Energiepreise wieder fallen!

Zu 2,39€

Nochmal 900 nachgelegt

Nochmal 2000 Stück zu 2,40€ nachgelegt. Was soll man machen...

Lächerlich, dafür fast 7% runter.🤦🏻‍♂️

Dividende erhalten 👍🏻